The Oldest Pharma Company in India: A Deep Dive into Serums & Vaccines Institute of India

Who actually holds the title of the oldest pharmaceutical company in India? It’s not a household name like Cipla or Sun Pharma. The answer is Serums and Vaccines Institute of India (SII), which was established in 1948. Originally founded as the Central Research Institute (CRI) in 1889 for research, it transitioned into manufacturing vaccines and serums commercially shortly after independence. This makes it the undisputed pioneer in the country's drug production landscape.

While many people assume that private giants like Dr. Reddy’s or Lupin are the oldest, they were founded decades later, mostly in the 1980s and 1990s. The Indian pharmaceutical industry has a unique history tied closely to public health needs during colonial times and the immediate post-independence era. Understanding who started it all helps us see how the sector evolved from basic vaccine production to becoming the "pharmacy of the world."

The True Pioneer: Serums and Vaccines Institute of India (SII)

To understand why SII is the oldest, we have to look at its roots. The institution began as the Plague Laboratory in Pune in 1896 under the British Raj. However, it wasn't a commercial pharmaceutical company yet. It was a research facility focused on combating infectious diseases like plague, cholera, and smallpox.

The real shift happened in 1948. After India gained independence, the government recognized the urgent need for a self-sufficient supply of life-saving vaccines. The organization was restructured and renamed the Serums and Vaccines Institute of India Limited (SVIL). It started manufacturing diphtheria antitoxin, tetanus antitoxin, and various vaccines. This marked the beginning of organized pharmaceutical manufacturing in the country.

SII remains a public sector undertaking today. Unlike private companies that focus heavily on generic drugs for profit, SII’s primary mandate has always been public health. They produce about 3 billion doses of vaccines annually. If you’ve ever received a polio drop or a DPT vaccine in India, there’s a high chance it came from them. Their longevity isn’t just about age; it’s about consistent contribution to national health security.

Early Private Players: The Post-Independence Boom

While SII holds the official title of the oldest manufacturer, the private sector played a crucial role in shaping the modern Indian pharma industry. Several companies emerged in the 1940s and 1950s, laying the groundwork for the generics boom that followed.

One notable early player is Cipla, founded in 1935 by Keshubhai Patel. Wait, 1935? Yes, Cipla was established earlier than SII’s commercial launch in 1948. However, Cipla initially operated as a chemical trading house and later moved into pharmaceutical formulation. For many years, it was considered one of the oldest *private* pharmaceutical companies. But technically, if we define "pharma company" as an entity engaged in the manufacturing of medicinal products for therapeutic use, SII’s institutional manufacturing capabilities predate Cipla’s large-scale drug production. Cipla truly entered the mainstream pharmaceutical manufacturing scene in the late 1940s and 1950s.

Another giant, Dabur, was founded even earlier, in 1884. But here’s the catch: Dabur primarily manufactures Ayurvedic medicines and consumer healthcare products, not allopathic pharmaceuticals. In the context of "pharma," most people refer to synthetic drugs and vaccines. So, while Dabur is older, it belongs to a different category-Ayurveda and wellness. If your definition of pharma includes traditional medicine, Dabur takes the crown. But for conventional western medicine, SII and Cipla are the key contenders.

Why the Distinction Matters

You might wonder why this distinction between "oldest" matters. It’s not just trivia. The history of these companies reflects the regulatory and economic shifts in India.

• Public vs. Private Mandate: SII was created to fill a gap left by the colonial government. Its existence proves that the state saw health as a public good. Private companies like Cipla grew because of market opportunities.
• Regulatory Evolution: Early companies operated with minimal regulation. Over time, bodies like the Central Drugs Standard Control Organization (CDSCO) introduced strict quality checks. Older companies had to adapt or shut down.
• Innovation Pathways: SII focused on biologics (vaccines), which require complex cold chains and biological expertise. Private firms focused on small-molecule generics, which were easier to manufacture and distribute.

This divergence shaped the entire industry. Today, India is a global leader in both vaccines and generic drugs. You can trace the vaccine leadership directly back to SII’s early investments in infrastructure and R&D.

The Rise of Modern Giants

Fast forward to the 1980s and 1990s. This period saw the rise of what we now consider the "big players." Companies like Lupin (founded 1968), Dr. Reddy’s Laboratories (1984), and Sun Pharma (1983) transformed the sector. They didn’t start as old institutions; they started as agile businesses ready to exploit changes in patent laws.

The Drug Price Control Order (DPCO) of 1970 capped prices on essential medicines. This forced companies to innovate in efficiency and scale. Later, the TRIPS agreement in the 1990s changed patent rules globally. Indian companies, already skilled at making generics due to lack of product patents before 1970, pivoted quickly to serve international markets.

These modern giants weren’t the oldest, but they became the largest. Sun Pharma, for instance, is now one of the biggest pharmaceutical companies in Asia by revenue. Yet, their origins are much younger compared to SII or Cipla. This highlights a key point: age doesn’t always equal size. Agility and strategic timing often matter more in business growth.

Common Misconceptions About Age

When searching for the oldest pharma company, you’ll encounter conflicting information online. Here’s why:

1. Ayurveda vs. Allopathy: As mentioned, Dabur (1884) and Himalaya Drug Company (1930) are very old. But they operate in the herbal/Ayurvedic space. If you’re looking for antibiotics or insulin producers, they don’t count.
2. Trading vs. Manufacturing: Some companies started as distributors or traders of foreign drugs before setting up their own factories. Cipla, for example, traded chemicals before manufacturing. When do you count the founding date? Usually, it’s when the entity was legally registered, regardless of initial activity.
3. Mergers and Acquisitions: Many old brands have been absorbed into larger conglomerates. For instance, some historic local manufacturers were bought by multinational corporations. Does the brand retain its "age"? Often, yes, but the corporate structure changes.

To avoid confusion, always clarify whether you mean "oldest manufacturing entity" or "oldest brand." SII wins on manufacturing continuity. Dabur wins on brand heritage. Cipla wins on private-sector longevity in allopathic drugs.

Impact on Global Health

The legacy of these old companies extends far beyond India’s borders. SII, for example, is a major supplier to the World Health Organization (WHO). During the COVID-19 pandemic, SII produced billions of doses of the Covishield vaccine in partnership with the Serum Institute of India (a separate private entity founded in 1966 by Adar Poonawalla). Note the difference: SII (public, 1948) and Serum Institute of India (private, 1966). Both are critical, but only SII is the oldest.

This dual presence-public and private-shows the strength of India’s pharma ecosystem. The old guard provided stability and public health coverage. The new guard provided scale and global reach. Together, they make India resilient against health crises.

Conclusion: Who Is the Oldest?

If you need a single name, it’s Serums and Vaccines Institute of India (SII). Founded in 1948, it has continuously manufactured vaccines and serums for over seven decades. If you include Ayurveda, Dabur (1884) is older. If you restrict it to private allopathic manufacturers, Cipla (1935) is the earliest registered entity, though its manufacturing ramp-up came slightly later.

Understanding this history gives you a clearer picture of the industry’s evolution. From colonial labs to global giants, the journey reflects India’s growing capability in science and medicine. Whether you’re an investor, a student, or a curious reader, knowing who started it all adds depth to your understanding of today’s pharma landscape.